Navigation Links
SinuNase Phase 3 show almost 100 percent of chronic sinusitis cases are from fungal-induced inflamma
Date:9/10/2007

l trial for CS and the only intranasal antifungal that has been submitted to the FDA as an Investigative New Drug (IND). The initial study population is with patients that have severe CS who have undergone sinus surgery, but who are struggling with recurrent CS.

Despite the fact that there are over 60 million patients in the U.S. and EU that have CS, and that CS is by far the most common chronic respiratory disease with a commercial market approximately twice the size of asthma, there is currently no approved prescription pharmaceutical available for treatment of the disease. If approved, SinuNase will be the first therapy available to treat sufferers of CS.

Accentia Biopharmaceuticals is commercializing SinuTest for the confirmation of CS. Investigators at Mayo discovered that a ubiquitous, normally innocuous mold, Alternaria, colonizes in the mucus of the nose and sinus of virtually everybody. However, it was found that in patients with CS, this non-invasive mold elicits an eosinophilic inflammatory response characterized by the release of eMBP in the mucus, which then damages the mucosal epithelial lining of the nose and sinuses, leading to the inflammatory mucosal changes characteristic of CS. The SinuTest diagnostic uses a small sample of mucus from the patient's nose and tests for eMBP, which is uniquely detectable in the nasal mucin of patients with CS.


'/>"/>

Contact: Adam Holdsworth
aholdsworth@investorrelationsgroup.com
212-825-3210
The Investor Relations Group
Source:Eurekalert

1

GOOD

Page: 1 2

Related biology news :

1. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
2. Worlds largest rainforest drying experiment completes first phase
3. Kinovate Life Sciences Launches Nittophase?High Performance Solid Support For Oligonucleatide Synthesis
4. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses
5. Eisai announces Phase II data on E7389, a potential new therapy for the treatment of breast cancer
6. Ebola DNA vaccine produces immune responses in all fully vaccinated volunteers in Phase 1 trial
7. NIH announces phase III clinical trial of creatine for Parkinsons disease
8. Farm kids almost twice as likely to die from injury as children overall
9. Chronic pain up almost 40 percent among US workers in past decade
10. Hunger in America rises by 43 percent over last five years
11. Method slashes quantum dot costs by 80 percent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... to learn new information and adapt to changes in our ... to lie in the minute junctions where nerve cells communicate, ... researchers. The study is published online this week in the ... Wen-Biao Gan, PhD, associate professor of physiology and neuroscience at ...
(Date:12/3/2009)... scientists believe that staph infections are caused by many bacterial ... process is called quorum sensing because many bacteria must be ... research group has determined that the very first stage of ... virulent form, occurs in a single cell and that this ...
(Date:12/3/2009)... Spanish researchers have measured CO2 levels for the past ... sparsely inhabited rural area near Valladolid. The results, which ... Peninsula, show that the levels rose "significantly" between 2002 ... have been trying to find out about carbon dioxide ...
Breaking Biology News(10 mins):Lifelong memories linked to stable nerve connections 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3CO2 levels rising in troposphere over rural areas 2Progressive Groups to Spend More Than 2482 Million to Ensure Real Health Care Reform Passes This Year 47516 1Progressive Groups to Spend More Than 2482 Million to Ensure Real Health Care Reform Passes This Year 47516 2Progressive Groups to Spend More Than 2482 Million to Ensure Real Health Care Reform Passes This Year 47516 3Niutang Sucralose Patent Litigation Successfully Concluded 47514 1Niutang Sucralose Patent Litigation Successfully Concluded 47514 2Niutang Sucralose Patent Litigation Successfully Concluded 47514 3Michael J Fox Foundation Announces Launch of PD Online Research 47512 1Michael J Fox Foundation Announces Launch of PD Online Research 47512 2Michael J Fox Foundation Announces Launch of PD Online Research 47512 3
... latest clinical trials, coronary artery bypass surgery performed on a ... a safe option that leads to fewer negative side effects ... Cardiac Surgery. , “Previously, it was more common for ... stopping the heart and passing the blood through a heart-lung ...
... for shock or stroke could be based on a protein ... article to be published in the November issue of The ... which may be the key to unlocking new therapies to ... Italian researchers suggest that neuroglobin is involved in the brain's ...
... Mechanical 'artificial hearts' can be used to return severely ... need for heart transplantation, according to new research. , ... (LVADs), are currently used in patients with very severe ... published in the New England Journal of Medicine, shows ...
Other Biology News:Mechanical 'artificial hearts' can remove need for heart transplant by returning heart to normal 2
(Date:12/4/2009)... and Technology (NIST) and the Naval Research Laboratory have ... a semiconductor crystal by prodding it with a scanning ... technique will enable researchers to selectively implant atoms in ... its electrical and magnetic properties on the atomic scale. ...
(Date:12/4/2009)... Alberta Centre for Advanced Micro Nano Technology Products ... seminar, , EDMONTON, Dec. 4 /PRNewswire/ - Today ... how technologies like nanotechnology, biomaterials and microfluidics can ... innovative healthcare products that help promote health and ...
(Date:12/4/2009)... Calif., Dec. 4 BlueFire Ethanol Fuels, Inc. (OTC Bulletin ... fuel paradigm through the production of ethanol from non-food cellulosic ... Digest list of the "50 Hottest Companies in Bioenergy;" ... ,, "Having voters rank BlueFire Ethanol among the top 20 ...
(Date:12/3/2009)... 3 Nikon Corporation, an innovator of advanced ... a licensing agreement with Harvard University granting Nikon ... Microscopy (STORM) technology. Under the terms of the ... and market them with the N-STORM name. ...
Breaking Biology Technology:NIST researchers put a new spin on atomic musical chairs 2Alberta companies delivering new products to the health & medical marketplace 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3
... of Berlin, Germany plans to acquire Roentec AG, ... $6-7 million, based in Berlin. Terms of the transaction were ... the fourth quarter of 2005. Bruker AXS has its North ... is estimated to be greater than $150 million per year, ...
... -- Sonic Foundry, Inc. has earned ... in 2003 to recognize and share expertise among companies ... certified status, Sonic Foundry achieved a Microsoft Competency in ... pleased to have earned certified status. The Microsoft Partner ...
... in Sendai, Japan, has purchased a LEAP 3000 metrology system made ... of Madison, Wis. The Tohoku University system is the third ... Imago delivered the system in conjunction with its representatives based in ... examining individual atoms, enabling metrology at the atomic scale. , , ...
Other Biology Technology:
... spin filters allow for the rapid isolation of ... DNA gel slice in the spin filter, centrifuge ... DNA is recovered. There is no need to ... Spin filters can also be used for buffer ...
Request Info...
...
Request Info...
Biology Products: